Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Introduction: As the availability of new economic evaluations (EE) on adjuvant trastuzumab therapy for early-stage breast cancer (EBC) with HER2-positive since last search and other EEs missed warrant a m...
Saved in:
Main Authors: | Anne Julienne Genuino, Mac Ardy Junio Gloria, Usa Chaikledkaew, Thanyanan Reungwetwattana, Ammarin Thakkinstian |
---|---|
Other Authors: | University of the Philippines Manila |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/59278 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
by: Anne Julienne Genuino, et al.
Published: (2020) -
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
by: Anne Julienne Genuino, et al.
Published: (2020) -
Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
by: Jitawatanarat,P., et al.
Published: (2015) -
Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
by: Potjana Jitawatanarat, et al.
Published: (2018) -
A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain
by: Mac Ardy Junio Gloria, et al.
Published: (2022)